KVUE logo

KVUE

Outside the watchlist

Kenvue Inc.

17.83

+0.73% (전일종가 17.70)

Loading chart...

Watchlist shortcuts

Edit

시장대표지수 (5)

섹터ETF (5)

AI·클라우드 (6)

비트코인·디지털자산 (5)

양자·원전·전력인프라 (7)

우주·항공 (3)

Company Analysis

Sector
Consumer Defensive
Industry
Household & Personal Products
Headquarters
Summit, United States
Employees
21,780

Company profile — from Yahoo Finance

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Company information as provided by Yahoo Finance. Check the official filings before relying on it.

Size · Range · Profitability

Market Cap

342억 달러

PER

20.7배

Trailing 12 months

Forward P/E

14.4배

Forward estimates

ROE

15.6%

Return on equity

Dividend Yield

4.7%

Beta

0.45

Volatility vs market

52주 최저 $14.02현재 $17.8352주 최고 $20.13

52주 범위에서 62% 지점입니다. 100%에 가까울수록 1년 최고가 부근입니다.

Source: Yahoo Finance

Wall Street Consensus

Average analyst price target

$19.50+9.4%

범위 $18.00 ~ $23.00 · 애널리스트 12명 · 종합의견 none · 출처 Yahoo Finance

Analyst rating breakdown (2026-09-01)

Strong Buy 2Buy 4Hold 14Sell 0Strong Sell 0

월가는 이 종목을 뚜렷한 매수 우위로 보고 있습니다. (매수 6 · 관망 14 · 매도 0)

Annual Financials

Revenue trend

151억 달러

2022–2025 회계연도 · 축 단위는 달러입니다.

2022202320242025$15.5B

Net income trend

15억 달러

2022–2025 회계연도 · 축 단위는 달러입니다.

2022202320242025$2.1B
YearRevenueOperating IncomeNet IncomeOperating Cash FlowNet Margin
2025151억 달러27억 달러15억 달러22억 달러9.7%
2024155억 달러26억 달러10억 달러18억 달러6.7%
2023154억 달러25억 달러17억 달러32억 달러10.8%
2022150억 달러27억 달러21억 달러25억 달러13.8%

회계연도 기준 실적입니다(달력 연도와 다를 수 있습니다). 출처: Yahoo Finance. 값이 없는 항목은 채우지 않고 "-"로 둡니다.

SEC Filings (latest 3)

Related News (latest 3)

What this ticker does not include

Prices, key stats, price targets, annual financials, filings and news above come straight from Yahoo Finance · Finnhub · SEC EDGAR, so they look the same for any US-listed ticker.

Support & resistance shows above whenever my TradingView indicator is sending alerts for the ticker. No alert is set up for this one yet, so there are no levels.
Option levels · MJM Score · REAL_BUY signals come through a Google Sheet and are still limited to the fixed watchlist. We leave them out rather than guess.